BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30726850)

  • 1. Association between Hypertension and the Risk of Parkinson's Disease: A Meta-Analysis of Analytical Studies.
    Chen J; Zhang C; Wu Y; Zhang D
    Neuroepidemiology; 2019; 52(3-4):181-192. PubMed ID: 30726850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of orthostatic hypotension with Parkinson's disease: a meta-analysis.
    Mu F; Jiao Q; Du X; Jiang H
    Neurol Sci; 2020 Jun; 41(6):1419-1426. PubMed ID: 32030568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and Diagnosis of Parkinson's Disease: A Meta-Analysis of Cohort Studies.
    Hou L; Li Q; Jiang L; Qiu H; Geng C; Hong JS; Li H; Wang Q
    Front Neurol; 2018; 9():162. PubMed ID: 29615961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies.
    Costa J; Lunet N; Santos C; Santos J; Vaz-Carneiro A
    J Alzheimers Dis; 2010; 20 Suppl 1():S221-38. PubMed ID: 20182023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus, prediabetes and the risk of Parkinson's disease: a systematic review and meta-analysis of 15 cohort studies with 29.9 million participants and 86,345 cases.
    Aune D; Schlesinger S; Mahamat-Saleh Y; Zheng B; Udeh-Momoh CT; Middleton LT
    Eur J Epidemiol; 2023 Jun; 38(6):591-604. PubMed ID: 37185794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis: Association of Helicobacter pylori infection with Parkinson's diseases.
    Shen X; Yang H; Wu Y; Zhang D; Jiang H
    Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28598012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between diabetes mellitus and risk of Parkinson's disease: A prisma-compliant meta-analysis.
    Liu W; Tang J
    Brain Behav; 2021 Aug; 11(8):e02082. PubMed ID: 34291588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Parkinson's disease and risk of colorectal cancer.
    Xie X; Luo X; Xie M
    Parkinsonism Relat Disord; 2017 Feb; 35():42-47. PubMed ID: 27913126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between depression and the subsequent risk of Parkinson's disease: A meta-analysis.
    Wang S; Mao S; Xiang D; Fang C
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():186-192. PubMed ID: 29859854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head injury and risk of Parkinson disease: a systematic review and meta-analysis.
    Jafari S; Etminan M; Aminzadeh F; Samii A
    Mov Disord; 2013 Aug; 28(9):1222-9. PubMed ID: 23609436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin use and risk of Parkinson's disease: A meta-analysis.
    Sheng Z; Jia X; Kang M
    Behav Brain Res; 2016 Aug; 309():29-34. PubMed ID: 27131781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between periodontal disease and the risk of myocardial infarction: a pooled analysis of observational studies.
    Xu S; Song M; Xiong Y; Liu X; He Y; Qin Z
    BMC Cardiovasc Disord; 2017 Feb; 17(1):50. PubMed ID: 28143450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Association between Statin Use and the Risk of Parkinson's Disease: A Meta-Analysis of Observational Studies.
    Poly TN; Islam MM; Walther BA; Yang HC; Nguyen PA; Huang CW; Shabbir SA; Li YJ
    Neuroepidemiology; 2017; 49(3-4):142-151. PubMed ID: 29145202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of serum cholesterol in Parkinson's disease: a meta-analysis of evidence.
    Gudala K; Bansal D; Muthyala H
    J Parkinsons Dis; 2013 Jan; 3(3):363-70. PubMed ID: 23948990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Parkinson's Disease and Risk of Cancer: A PRISMA-compliant Meta-analysis.
    Zhang P; Liu B
    ACS Chem Neurosci; 2019 Oct; 10(10):4430-4439. PubMed ID: 31584793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial coaggregation of Alzheimer's disease and Parkinson's disease: systematic review and meta-analysis.
    Feldman AL; Johansson AL; Lambert PC; Sieurin J; Yang F; Pedersen NL; Wirdefeldt K
    Neuroepidemiology; 2014; 42(2):69-80. PubMed ID: 24296900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of catechol-o-methyltransferase polymorphism (Val108/158Met) with Parkinson's disease: a meta-analysis.
    Wang Y; Yang X
    J Mot Behav; 2012; 44(5):365-72. PubMed ID: 23035936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association between Toxoplasma gondii Infection and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Zhou Z; Zhou R; Li K; Wei W; Zhang Z; Zhu Y; Luan R
    Biomed Res Int; 2019; 2019():8186017. PubMed ID: 30931331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid Dysfunction and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Charoenngam N; Rittiphairoj T; Ponvilawan B; Prasongdee K
    Front Endocrinol (Lausanne); 2022; 13():863281. PubMed ID: 35600588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2D6 phenotypes and Parkinson's disease risk: a meta-analysis.
    Lu Y; Peng Q; Zeng Z; Wang J; Deng Y; Xie L; Mo C; Zeng J; Qin X; Li S
    J Neurol Sci; 2014 Jan; 336(1-2):161-8. PubMed ID: 24211060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.